Abstract
The purpose of this study was to ascertain the onset expression of pro-inflammatory cytokines in the aorta and kidney and establish their correlation with the increase in arterial blood pressure in rats subjected to DOCA-salt treatment. Male Sprague–Dawley rats underwent unilateral nephrectomy and received subcutaneous DOCA (20 mg/rat/week) as well as 1% NaCl and 0.2% KCl for drinking for 2 weeks. Blood pressure and expression of pro-inflammatory cytokines in aorta and kidney were studied weekly during the induction of hypertension. The treated rats exhibited a mild elevation of blood pressure at 1 week and a profound increase at 2 weeks. Quantitative RT-PCR demonstrated a 4.9-fold and a 3.6-fold enhancement in the expression of TNF-α and IL-6, respectively, in aorta as early as 1 week. The expression of IL-6 and TNF-α in the kidney remained almost unchanged at 1 week but mildly increased at 2 weeks DOCA-salt treatment. This study indicates a robust increase in the expression of IL-6 and TNF-α in aorta in DOCA-salt treated rats. This enhancement suggests that the activation of pro-inflammatory cytokines may contribute to onset of the elevation of blood pressure in DOCA-salt hypertension model.
Similar content being viewed by others
References
Kim HY, Kang YJ, Song IH, Choi HC, Kim HS (2008) Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertens Res 31:515–523. doi:10.1291/hypres.31.515
Rodriguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Mezzano S, Vaziri ND (2005) Early and sustained inhibition of nuclear factor-kappa B prevents hypertension in spontaneously hypertensive rats. J Pharmacol Exp Ther 315:51–57. doi:10.1124/jpet.105.088062
Obst M, Gross V, Luft FC (2004) Systemic hemodynamics in non-anesthetized L-NAME- and DOCA-salt-treated mice. J Hypertens 22:1889–1894. doi:10.1097/00004872-200410000-00010
Elmarakby AA, Quigley JE, Pollock DM, Imig JD (2006) Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension 47:557–562. doi:10.1161/01.HYP.0000198545.01860.90
Guzik TJ, Hoch NE, Brown KA et al (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204:2449–2460. doi:10.1084/jem.20070657
Miyazawa K, Fukuyama J, Misawa K, Hamano S, Ujiie A (1996) Tranilast antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells. Atherosclerosis 121:167–173. doi:10.1016/0021-9150(95)05709-9
Kagitani S, Ueno H, Hirade S, Takahashi T, Takata M, Inoue H (2004) Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats. J Hypertens 22:1007–1015. doi:10.1097/00004872-200405000-00024
Navarro JF, Milena FJ, Mora C, Leon C, Garcia J (2006) Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Am J Nephrol 26:562–570. doi:10.1159/000098004
Navarro JF, Mora-Fernandez C (2006) The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev 17:441–450. doi:10.1016/j.cytogfr.2006.09.011
Dahl LK, Heine M, Tassinari L (1963) Effects of chronic excess salt ingestion. Role of genetic factors in both doca-salt and renal hypertension. J Exp Med 118:605–617. doi:10.1084/jem.118.4.605
Coles B, Fielding CA, Rose-John S, Scheller J, Jones SA, O’Donnell VB (2007) Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo. Am J Pathol 171:315–325. doi:10.2353/ajpath.2007.061078
Fernandez-Real JM, Vayreda M, Richart C et al (2001) Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86:1154–1159. doi:10.1210/jc.86.3.1154
Vazquez-Oliva G, Fernandez-Real JM, Zamora A, Vilaseca M, Badimon L (2005) Lowering of blood pressure leads to decreased circulating interleukin-6 in hypertensive subjects. J Hum Hypertens 19:457–462. doi:10.1038/sj.jhh.1001845
Orshal JM, Khalil RA (2004) Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats. Hypertension 43:434–444. doi:10.1161/01.HYP.0000113044.46326.98
Francis J, Beltz T, Johnson AK, Felder RB (2003) Mineralocorticoids act centrally to regulate blood-borne tumor necrosis factor-alpha in normal rats. Am J Physiol 285:R1402–R1409. doi:10.1152/ajpregu.00027.2003
Acknowledgments
These studies were supported by a grant from Tehran Medical Sciences University (to MK), and the National Institute of Health Grant DK 62829 (to MS).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seifi, B., Kadkhodaee, M., Xu, J. et al. Pro-inflammatory cytokines of rat vasculature in DOCA-salt treatment. Mol Biol Rep 37, 2111–2115 (2010). https://doi.org/10.1007/s11033-009-9676-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-009-9676-2